This study will assess platelet function and safety in healthy male volunteers following
doses of intravenous diclofenac compared to oral diclofenac (Cataflam), intravenous
ketorolac and oral aspirin.
The primary objective is to evaluate platelet function following intravenous diclofenac,
oral diclofenac (Cataflam), intravenous ketorolac and oral aspirin.
- Healthy male subjects.
- Willing and able to stay at the clinical site for approximately 8 nights over 9 days
and to return to the clinic approximately 7 days after discharge.
- Bleeding abnormalities or cardiovascular events.
- Known allergy or hypersensitivity to the active compounds or any of the excipients
used in the study.